The study will include 5 cohorts. After each cohort, optimisation of the Spiden Clinical Demo 2.0 system and machine learning models may be pursued before the next cohort is started. Trial participants with type 1 or type 2 diabetes mellitus.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female trial participant with clinically diagnosed type 1 or type 2 diabetes for at least 1 year.
Age between 18 and 65 years, both inclusive.
Treated with insulin and/or oral antidiabetic drugs (OADs; type 2 only), multiple dosing insulin therapy (MDI), continuous subcutaneous insulin infusion (CSII) or a hybrid closed loop system.
You may not be if
Known or suspected hypersensitivity to any of the components of the Liom Clinical Demo 2.0.
Trial participant with any injury, infection, atypical skin condition (e.g., hyperkeratosis, hyperpigmentation) of or tattoo on the wrists.
Presence or history of a cardiovascular disease including stable and unstable angina pectoris, myocardial infarction, transient ischaemic attack, stroke, cardiac decompensation, clinically significant arrhythmias or clinically significant conduction disorders.
